glp 1 agonist osteoporosis GLP-1 Use Associated with Lower Risk in Adults with Type 2 Diabetes but Higher Risk in Adults Without Diabetes Positive impact of GIP, GLP-1

This article thoroughly traces the developmental milestones of GLP-1 drugs, from their initial discovery to their clinical application, detailing the evolution of diverse GLP-1 medications along with their distinct pharmacological properties

With the emergence of various classes of blood glucose-lowering agents, choosing the appropriate drug for each patient is emphasized in diabetes management

Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.

Get Guidance from Set Point.

Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent

But new research suggests theres another reason they work so well they may actually help your body burnmore of the most dangerous kind of fat.What Is Visceral Fat?Visceral fat is the fat stored deep inside your abdomen, wrapped around your organs.Its different from the fat under your skin and its much harder to lose.Too much visce